Accuflex DX Solutions

Rapid Diagnostics

Rapid diagnostic solutions for clinics and laboratories across Malaysia, including respiratory antigen testing, dengue testing and selected point-of-care applications.

Accuflex DX supports your testing requirements through product consultation, responsive local supply and application assistance.

For professional in vitro diagnostic use only. Product information on this page is drawn from manufacturer documentation.

Why Accuflex

Product Selection

Rapid tests suited to different testing requirements and clinical workflows.

Responsive Local Supply

Local assistance with product enquiries, availability and replenishment.

Application Support

Help with product selection, implementation considerations and technical enquiries.

Respiratory Rapid Testing

Respiratory infections share overlapping symptoms, so the range of targets a rapid test covers is a practical consideration. Rapid antigen tests detect selected pathogen antigens, whereas molecular assays such as PCR detect nucleic acids. Their analytical characteristics and clinical applications differ. For the molecular option, see Respiratory Molecular Diagnostics.

EuroGen 12-in-1 Respiratory Panel Detection

One product family, two cassette designs — the same 12 targets

Cat. P2099 / P2099F
Targets (12)
SARS-CoV-2 (COVID-19), influenza A, influenza B, RSV, adenovirus, human metapneumovirus, human rhinovirus, human bocavirus, Mycoplasma pneumoniae, parainfluenza viruses 1, 2 and 3
Specimen
Nasopharyngeal or oropharyngeal swab
Assay readout time
15 minutes
Pack size
20 tests per kit
Cassette designs
VariantP2099P2099F
Cassette designSix-strip cassetteFan-shaped cassette
Sample wellsSixOne
Storage (per manufacturer)4 to 30 °CSee package insert
Enquire About This Test

EuroGen COVID-19/Flu A+B Antigen Combo Rapid Test

Qualitative detection and differentiation of SARS-CoV-2, influenza A and influenza B antigens

Cat. P2007
Targets
SARS-CoV-2, influenza A, influenza B
Specimen
Nasal or nasopharyngeal swab
Format
Two strips — influenza A/B and SARS-CoV-2
Assay readout time
15 minutes
Pack size
20 tests per kit
Storage (per manufacturer)
4 to 30 °C, out of direct sunlight, do not freeze
Enquire About This Test

Atida Multi-Respiratory Antigen Test

Manufactured by Aceso Laboratories, Inc.

Cat. SW55-RT9
Targets
Adenovirus, human parainfluenza virus (types I to III), RSV, SARS-CoV-2, rhinovirus, Mycoplasma pneumoniae, influenza A, influenza B, human metapneumovirus
Specimen
Nasal or nasopharyngeal swab
Format
Five-strip cassette
Assay readout time
15 minutes
Pack size
20 tests per kit
Enquire About This Test

12-in-1 and 9-in-1 are the manufacturers’ own product designations. The counts use each manufacturer’s convention and are not directly comparable measures of clinical coverage or diagnostic performance. Analytes are listed in full on each card.

Dengue Rapid Testing

Dengue testing commonly addresses two kinds of marker. The NS1 antigen is a viral protein that can be present during dengue infection. IgM and IgG antibodies are produced by the immune response and, taken together, can indicate recent or past exposure to dengue. A test that reports both kinds of marker gives the clinical team complementary information, which must be interpreted alongside the patient’s presentation.

EuroGen Dengue Virus NS1 Ag & IgG/IgM Ab Combo Rapid Test

Combined antigen and antibody detection in one cassette

Cat. P2056
Detects
Dengue NS1 antigen, and dengue IgM and IgG antibodies
Specimen
Whole blood, serum or plasma
Format
Dual-strip cassette — one strip for NS1 antigen, one for IgG/IgM
Assay readout time
15 minutes
Pack size
20 tests per kit
Enquire About This Test

NS1 antigen and IgM/IgG antibody results reflect different aspects of the viral and immune response and must be interpreted alongside the clinical presentation and, where required, confirmatory testing.

HIV & Gastrointestinal — Coming Soon

Two further rapid-test ranges are planned for the portfolio, listed here so that clinics and laboratories can register interest ahead of availability.

HIV 4th-Generation Combination Rapid Test

Coming Soon

A 4th-generation HIV combination rapid test — detecting HIV-1/2 antibodies together with HIV-1 p24 antigen in a single test — is planned for the Accuflex DX rapid-testing portfolio. Detailed product information will be published once the product documentation is confirmed.

A reactive HIV rapid screening result requires further testing according to the applicable national diagnostic algorithm. Results should be interpreted by qualified healthcare professionals.

Enquire for Updates

Gastrointestinal Combination Rapid Test

Coming Soon

A rapid gastrointestinal combination test is planned for the Accuflex DX portfolio. Detailed product information will be published when the manufacturer’s documentation is available.

Enquire for Updates

Other Rapid Tests

Further rapid-testing applications in the Accuflex DX portfolio.

Understanding Rapid Test Results

Rapid tests on this page are qualitative tests for professional in vitro diagnostic use. Results are interpreted according to the instructions supplied with each product and must be read by qualified healthcare professionals alongside clinical findings.

Product information. Product specifications are based on manufacturer information and may vary by product variant. Stated assay readout times do not represent total patient turnaround. All tests should be used according to their current instructions for use, intended purpose and applicable regulatory requirements. Contact Accuflex DX for product documentation, availability and registration information.

Associated Principals

Global manufacturers backing the solutions in this area. Their official websites open in a new tab.

Let's talk diagnostics

Have a question about our diagnostic solutions? We'd love to hear from you.

Enquire Now